Light sedation with dexmedetomidine: a practical approach for the intensivist in different ICU patients

Stefano Romagnoli, Angela Amigoni, Ilaria Blangetti, Giampaolo Casella, Cosimo Chelazzi, Francesco Forfori, Cristiana Garisto, Maria C Mondardini, Marco Moltrasio, Daniela Pasero, Tiziana Principi, Zaccaria Ricci, Fabio Tarantino, Giorgio Conti

Research output: Contribution to journalArticle

Abstract

Light sedation, corresponding to a Richmond Agitation-Sedation Scale between 0 and -1 is a priority of modern critical care practice. Dexmedetomidine, a highly selective, central, α2-adrenoceptor agonist, is increasingly administered in the intensive care units (ICUs) as an effective drug to induce light sedation, analgesia and a quasi-physiological sleep in critically ill patients. Although in general dexmedetomidine is well tolerated, side effects as bradycardia, hypertension, and hypotension may occur. Although a general dosing range is suggested, different ICU patients may require different and highly precise titration that may significantly vary due to neurological status, cardio-respiratory function, base-line blood pressure, heart rate, liver efficiency, age and co-administration of other sedatives. This review analyzes the use of dexmedetomidine in different settings including pediatric, adult, medical and surgical patients starting with some considerations on delirium prevention and sleep quality in critically ill patients and how dexmedetomidine may contribute to these crucial aspects. Dexmedetomidine use in specific sub-populations with unique characteristics will be detailed, with a special attention to a safe use.

Original languageEnglish
Pages (from-to)731-746
Number of pages16
JournalMinerva Anestesiologica
Volume84
Issue number6
DOIs
Publication statusPublished - Jun 2018

Fingerprint

Dexmedetomidine
Intensive Care Units
Light
Critical Illness
Sleep
Delirium
Critical Care
Bradycardia
Hypnotics and Sedatives
Hypotension
Analgesia
Adrenergic Receptors
Heart Rate
Pediatrics
Blood Pressure
Hypertension
Liver
Pharmaceutical Preparations
Population

Cite this

Romagnoli, S., Amigoni, A., Blangetti, I., Casella, G., Chelazzi, C., Forfori, F., ... Conti, G. (2018). Light sedation with dexmedetomidine: a practical approach for the intensivist in different ICU patients. Minerva Anestesiologica, 84(6), 731-746. https://doi.org/10.23736/S0375-9393.18.12350-9

Light sedation with dexmedetomidine : a practical approach for the intensivist in different ICU patients. / Romagnoli, Stefano; Amigoni, Angela; Blangetti, Ilaria; Casella, Giampaolo; Chelazzi, Cosimo; Forfori, Francesco; Garisto, Cristiana; Mondardini, Maria C; Moltrasio, Marco; Pasero, Daniela; Principi, Tiziana; Ricci, Zaccaria; Tarantino, Fabio; Conti, Giorgio.

In: Minerva Anestesiologica, Vol. 84, No. 6, 06.2018, p. 731-746.

Research output: Contribution to journalArticle

Romagnoli, S, Amigoni, A, Blangetti, I, Casella, G, Chelazzi, C, Forfori, F, Garisto, C, Mondardini, MC, Moltrasio, M, Pasero, D, Principi, T, Ricci, Z, Tarantino, F & Conti, G 2018, 'Light sedation with dexmedetomidine: a practical approach for the intensivist in different ICU patients', Minerva Anestesiologica, vol. 84, no. 6, pp. 731-746. https://doi.org/10.23736/S0375-9393.18.12350-9
Romagnoli, Stefano ; Amigoni, Angela ; Blangetti, Ilaria ; Casella, Giampaolo ; Chelazzi, Cosimo ; Forfori, Francesco ; Garisto, Cristiana ; Mondardini, Maria C ; Moltrasio, Marco ; Pasero, Daniela ; Principi, Tiziana ; Ricci, Zaccaria ; Tarantino, Fabio ; Conti, Giorgio. / Light sedation with dexmedetomidine : a practical approach for the intensivist in different ICU patients. In: Minerva Anestesiologica. 2018 ; Vol. 84, No. 6. pp. 731-746.
@article{a5b88f43f8d042dd892f4d2ad2089802,
title = "Light sedation with dexmedetomidine: a practical approach for the intensivist in different ICU patients",
abstract = "Light sedation, corresponding to a Richmond Agitation-Sedation Scale between 0 and -1 is a priority of modern critical care practice. Dexmedetomidine, a highly selective, central, α2-adrenoceptor agonist, is increasingly administered in the intensive care units (ICUs) as an effective drug to induce light sedation, analgesia and a quasi-physiological sleep in critically ill patients. Although in general dexmedetomidine is well tolerated, side effects as bradycardia, hypertension, and hypotension may occur. Although a general dosing range is suggested, different ICU patients may require different and highly precise titration that may significantly vary due to neurological status, cardio-respiratory function, base-line blood pressure, heart rate, liver efficiency, age and co-administration of other sedatives. This review analyzes the use of dexmedetomidine in different settings including pediatric, adult, medical and surgical patients starting with some considerations on delirium prevention and sleep quality in critically ill patients and how dexmedetomidine may contribute to these crucial aspects. Dexmedetomidine use in specific sub-populations with unique characteristics will be detailed, with a special attention to a safe use.",
author = "Stefano Romagnoli and Angela Amigoni and Ilaria Blangetti and Giampaolo Casella and Cosimo Chelazzi and Francesco Forfori and Cristiana Garisto and Mondardini, {Maria C} and Marco Moltrasio and Daniela Pasero and Tiziana Principi and Zaccaria Ricci and Fabio Tarantino and Giorgio Conti",
year = "2018",
month = "6",
doi = "10.23736/S0375-9393.18.12350-9",
language = "English",
volume = "84",
pages = "731--746",
journal = "Minerva Anestesiologica",
issn = "0375-9393",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - Light sedation with dexmedetomidine

T2 - a practical approach for the intensivist in different ICU patients

AU - Romagnoli, Stefano

AU - Amigoni, Angela

AU - Blangetti, Ilaria

AU - Casella, Giampaolo

AU - Chelazzi, Cosimo

AU - Forfori, Francesco

AU - Garisto, Cristiana

AU - Mondardini, Maria C

AU - Moltrasio, Marco

AU - Pasero, Daniela

AU - Principi, Tiziana

AU - Ricci, Zaccaria

AU - Tarantino, Fabio

AU - Conti, Giorgio

PY - 2018/6

Y1 - 2018/6

N2 - Light sedation, corresponding to a Richmond Agitation-Sedation Scale between 0 and -1 is a priority of modern critical care practice. Dexmedetomidine, a highly selective, central, α2-adrenoceptor agonist, is increasingly administered in the intensive care units (ICUs) as an effective drug to induce light sedation, analgesia and a quasi-physiological sleep in critically ill patients. Although in general dexmedetomidine is well tolerated, side effects as bradycardia, hypertension, and hypotension may occur. Although a general dosing range is suggested, different ICU patients may require different and highly precise titration that may significantly vary due to neurological status, cardio-respiratory function, base-line blood pressure, heart rate, liver efficiency, age and co-administration of other sedatives. This review analyzes the use of dexmedetomidine in different settings including pediatric, adult, medical and surgical patients starting with some considerations on delirium prevention and sleep quality in critically ill patients and how dexmedetomidine may contribute to these crucial aspects. Dexmedetomidine use in specific sub-populations with unique characteristics will be detailed, with a special attention to a safe use.

AB - Light sedation, corresponding to a Richmond Agitation-Sedation Scale between 0 and -1 is a priority of modern critical care practice. Dexmedetomidine, a highly selective, central, α2-adrenoceptor agonist, is increasingly administered in the intensive care units (ICUs) as an effective drug to induce light sedation, analgesia and a quasi-physiological sleep in critically ill patients. Although in general dexmedetomidine is well tolerated, side effects as bradycardia, hypertension, and hypotension may occur. Although a general dosing range is suggested, different ICU patients may require different and highly precise titration that may significantly vary due to neurological status, cardio-respiratory function, base-line blood pressure, heart rate, liver efficiency, age and co-administration of other sedatives. This review analyzes the use of dexmedetomidine in different settings including pediatric, adult, medical and surgical patients starting with some considerations on delirium prevention and sleep quality in critically ill patients and how dexmedetomidine may contribute to these crucial aspects. Dexmedetomidine use in specific sub-populations with unique characteristics will be detailed, with a special attention to a safe use.

U2 - 10.23736/S0375-9393.18.12350-9

DO - 10.23736/S0375-9393.18.12350-9

M3 - Article

C2 - 29405671

VL - 84

SP - 731

EP - 746

JO - Minerva Anestesiologica

JF - Minerva Anestesiologica

SN - 0375-9393

IS - 6

ER -